Ipilimumab-associated bilateral optic neuropathy

Journal of Neuro-Ophthalmology

Volumn 35, Issue 2, 2015, Pages 144-147

  Yeh, Oliver L ^a   Francis, Courtney E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; IPILIMUMAB; PREDNISOLONE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

AGED; ANTERIOR EYE CHAMBER; ARTICLE; ATRIAL FIBRILLATION; BILATERAL OPTIC NEUROPATHY; BLURRED VISION; CANCER STAGING; CARDIOVERSION; CASE REPORT; COLOR VISION; DRUG INFUSION; EYE DISEASE; EYE EDEMA; EYE SYNECHIA; HUMAN; IRIDOCYCLITIS; LYMPH NODE DISSECTION; MALE; METASTATIC MELANOMA; MONOTHERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PAPILLEDEMA; PHOTOPSIA; PRIORITY JOURNAL; SKIN BIOPSY; SLIT LAMP; THIGH; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; CHEMICALLY INDUCED; DRUG EFFECTS; MELANOMA; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY;

AGED; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOLOGIC FACTORS; MALE; MELANOMA; OPTIC NERVE DISEASES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 84930179528     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0000000000000217     Document Type: Article

References (8)

1. Andrews S, Holden R. Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res. 2012;4:299-307.
2. Robinson MR, Chan C, Yang JC, Rubin BI, Gracia GJ, Sen HN, Csaky KG, Rosenberg SA. Cytotoxic T lymphocyteassociated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother. 2004;27:478-479.
3. Weber JS, Kahler KC, Hauschild A. Management of immunerelated adverse events and kinetics of response with ipilimumab. J Clin Oncol. 2012;30:2691-2697.
4. Tarhini A, Lo E, Minor DR. Releasing the brake on the immune system: ipilimumab in melanoma and other tumors. Cancer Biother Radiopharm. 2010;25:601-613.
5. Walsh R, Galetta S, Tamhanker M. Ipilimumab-associated optic neuropathy. Paper presented at: Annual Meeting of the North American Neuro-Ophthalmology Society; February 14, 2012; San Antonio, TX.
6. FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files. Food and Drug Administration, 2014. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInfor mation/Surveillance/AdverseDrugEffects/ucm082193.htm. Accessed May 17, 2014.
7. Fong L, Small EJ. Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment. J Clin Oncol. 2008;26:5275-5283.
8. Min L, Vaidya A, Becker C. Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. Eur J Endocrinol. 2011;164:303-307.